Toyka, Klaus V.

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis

Ochs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 302

Animal models for autoimmune demyelinating disorders of the nervous system

Gold, R., Hartung, H.-P., & Toyka, K. V. (2000) · Molecular Medicine Today

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 292

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis

Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine

T-cell and B-cell ImmunologyMultiple Sclerosis Research Studies

Cited by 203

Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition

Werner, C., Pauli, M., Doose, S., Weishaupt, A., Haselmann, H., Grünewald, B., Sauer, M., Heckmann, M., Toyka, K. V., Asan, E., et al. (2016) · Brain

Autoimmune Neurological Disorders and TreatmentsNeuroscience and Neuropharmacology Research

Cited by 75

Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies

Schmidt, J., Elflein, K., Stienekemeier, M., Rodriguez-Palmero, M., Schneider, C., Toyka, K. V., Gold, R., & Hünig, T. (2003) · Journal of Neuroimmunology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 59